Medical image of the week: evolution of low grade adenocarcinoma
Ground glass lesions above 5 mm in greatest diameter found on chest computed tomography (CT) require initial followed up in 3 months according to the Fleischner Society Guidelines, to exclude a transient inflammatory focus (1). If persistent, surveillance for at least 24 months to confirm stability...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Arizona Thoracic Society
2017-03-01
|
Series: | Southwest Journal of Pulmonary and Critical Care |
Subjects: | |
Online Access: | http://www.swjpcc.com/imaging/2017/3/8/medical-image-of-the-week-evolution-of-low-grade-adenocarcin.html?SSScrollPosition=359 |
id |
doaj-23fb13e65b244eccbf8772929b5f7e09 |
---|---|
record_format |
Article |
spelling |
doaj-23fb13e65b244eccbf8772929b5f7e092020-11-25T01:51:51ZengArizona Thoracic SocietySouthwest Journal of Pulmonary and Critical Care2160-67732017-03-0114310310310.13175/swjpcc026-17Medical image of the week: evolution of low grade adenocarcinomaPalacio D 0Schmit B 1Arteaga V2University of Arizona, Tucson, AZ USAUniversity of Arizona, Tucson, AZ USAUniversity of Arizona, Tucson, AZ USAGround glass lesions above 5 mm in greatest diameter found on chest computed tomography (CT) require initial followed up in 3 months according to the Fleischner Society Guidelines, to exclude a transient inflammatory focus (1). If persistent, surveillance for at least 24 months to confirm stability is recommended. Any change in size or density should warrant further action, ideally surgical consultation, given the suboptimal yield of percutaneous biopsy and risk of inappropriate staging if the whole lesion is not examined. This may result in the inability to recognize the transition from in-situ adenocarcinoma into minimally invasive or invasive lesions, which in turn results in inaccurate staging and prognosis.http://www.swjpcc.com/imaging/2017/3/8/medical-image-of-the-week-evolution-of-low-grade-adenocarcin.html?SSScrollPosition=359lungcanceradenocarcinomaCT scanground glass opacityFleishner Societythoracicserialmassnodule |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Palacio D Schmit B Arteaga V |
spellingShingle |
Palacio D Schmit B Arteaga V Medical image of the week: evolution of low grade adenocarcinoma Southwest Journal of Pulmonary and Critical Care lung cancer adenocarcinoma CT scan ground glass opacity Fleishner Society thoracic serial mass nodule |
author_facet |
Palacio D Schmit B Arteaga V |
author_sort |
Palacio D |
title |
Medical image of the week: evolution of low grade adenocarcinoma |
title_short |
Medical image of the week: evolution of low grade adenocarcinoma |
title_full |
Medical image of the week: evolution of low grade adenocarcinoma |
title_fullStr |
Medical image of the week: evolution of low grade adenocarcinoma |
title_full_unstemmed |
Medical image of the week: evolution of low grade adenocarcinoma |
title_sort |
medical image of the week: evolution of low grade adenocarcinoma |
publisher |
Arizona Thoracic Society |
series |
Southwest Journal of Pulmonary and Critical Care |
issn |
2160-6773 |
publishDate |
2017-03-01 |
description |
Ground glass lesions above 5 mm in greatest diameter found on chest computed tomography (CT) require initial followed up in 3 months according to the Fleischner Society Guidelines, to exclude a transient inflammatory focus (1). If persistent, surveillance for at least 24 months to confirm stability is recommended. Any change in size or density should warrant further action, ideally surgical consultation, given the suboptimal yield of percutaneous biopsy and risk of inappropriate staging if the whole lesion is not examined. This may result in the inability to recognize the transition from in-situ adenocarcinoma into minimally invasive or invasive lesions, which in turn results in inaccurate staging and prognosis. |
topic |
lung cancer adenocarcinoma CT scan ground glass opacity Fleishner Society thoracic serial mass nodule |
url |
http://www.swjpcc.com/imaging/2017/3/8/medical-image-of-the-week-evolution-of-low-grade-adenocarcin.html?SSScrollPosition=359 |
work_keys_str_mv |
AT palaciod medicalimageoftheweekevolutionoflowgradeadenocarcinoma AT schmitb medicalimageoftheweekevolutionoflowgradeadenocarcinoma AT arteagav medicalimageoftheweekevolutionoflowgradeadenocarcinoma |
_version_ |
1724995999711100928 |